Percutaneous ventricular assist devices for percutaneous coronary interventions in older patients with heart failure: a target trial emulation

医学 传统PCI 心脏病学 内科学 经皮冠状动脉介入治疗 心力衰竭 围手术期 经皮 危险系数 倾向得分匹配 射血分数 比例危险模型 冠状动脉疾病 狼牙棒 入射(几何) 血运重建 心理干预 心肌梗塞 血管成形术 蒂米 支架 阿昔单抗 心室辅助装置 射血分数保留的心力衰竭 介入心脏病学 弗雷明翰风险评分 肌钙蛋白 低风险
作者
Atsuyuki Watanabe,Yoshihisa Miyamoto,Hiroki A Ueyama,Kosuke Inoue,Roger Laham,Deepak L. Bhatt,Yusuke Tsugawa,Toshiki Kuno
出处
期刊:Heart [BMJ]
卷期号:: heartjnl-2025
标识
DOI:10.1136/heartjnl-2025-326949
摘要

Background Percutaneous ventricular assist devices (pVAD) have been increasingly used to support haemodynamics during percutaneous coronary interventions (PCI). Since older patients with coronary artery disease and heart failure (HF) are less likely to undergo open heart surgery, given the higher risk of perioperative complications, the analyses on the benefits of pVAD for older patients with HF receiving PCI will be informative. Methods We included Medicare fee-for-service beneficiaries aged 65–99 years with systolic HF receiving PCI from 2017 to 2020. Using a target trial emulation framework, we followed the patients from the date of the index PCI to the maximum of 1 year and examined the incidence of major adverse cardiovascular events (MACE: composite of all-cause mortality, HF readmission, acute myocardial infarction, and stroke), as well as in-hospital outcomes, including postprocedural transfusions, of patients treated with PCI plus pVAD versus PCI plus intra-aortic balloon pump (IABP). We used the propensity score matching approach to control for 58 baseline covariates and applied a Cox regression model to estimate adjusted hazard ratio (aHR). Results We included 5823 patients, from whom 2096 patients were matched. The risk of 1-year MACE was 55.4% (95% CI 52.2–58.5) in the pVAD group versus 54.7% (95% CI 51.4 to 57.8) in the IABP group, with aHR of 0.95 (95% CI 0.83 to 1.10). We did not find evidence that other outcomes differed between patients treated with PCI plus pVAD versus PCI plus IABP, including 1-year mortality (aHR, 0.94; 95% CI,0.79 to 1.12) and postprocedural transfusions (adjusted risk ratio, 1.07; 95% CI 0.75 to 1.52). Our findings were consistent across several sensitivity analyses. Conclusions This observational study using the Medicare databases in the USA did not find evidence that clinical outcomes differed between older patients with systolic HF receiving PCI with pVAD vs PCI plus IABP.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
在水一方的应助被叶迎采纳,获得10
刚刚
温暖砖头发布了新的文献求助10
刚刚
chen发布了新的文献求助20
1秒前
小蘑菇的应助被阔达的冷霜采纳,获得10
1秒前
仰望苍穹完成签到,获得积分10
2秒前
serein发布了新的文献求助30
2秒前
sjssss完成签到,获得积分10
2秒前
大个的应助被欣喜的香彤采纳,获得10
3秒前
SciGPT的应助被健康的宛菡采纳,获得10
3秒前
无极微光的应助被健康的宛菡采纳,获得20
4秒前
星辰大海的应助被健康的宛菡采纳,获得10
4秒前
orixero的应助被健康的宛菡采纳,获得10
4秒前
顾矜的应助被健康的宛菡采纳,获得10
4秒前
4秒前
上官若男的应助被健康的宛菡采纳,获得10
5秒前
墩子发布了新的文献求助20
5秒前
不爱喝酒的应助被CS采纳,获得10
6秒前
Kate完成签到 ,获得积分10
6秒前
6秒前
Wuyuan50发布了新的文献求助10
6秒前
7秒前
英俊的铭的应助被高能量采纳,获得20
7秒前
搜集达人的应助被榛子田采纳,获得10
7秒前
8秒前
8秒前
8秒前
田様的应助被破晓布朗尼采纳,获得10
9秒前
9秒前
10秒前
10秒前
科研通AI65的应助被Zhangyuanjie采纳,获得30
11秒前
11秒前
igiss发布了新的文献求助10
11秒前
复杂千亦发布了新的文献求助10
11秒前
12秒前
123发布了新的文献求助10
12秒前
Jenna完成签到,获得积分10
12秒前
13秒前
大个的应助被涤宇采纳,获得10
13秒前
星星完成签到,获得积分20
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183204
求助须知:如何正确求助?哪些是违规求助? 9572482
关于积分的说明 21825940
捐赠科研通 7780074
什么是DOI,文献DOI怎么找? 3433945
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480166